|
Volumn 38, Issue 9, 2015, Pages 520-526
|
Insights into statin intolerance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
ATORVASTATIN;
BILE ACID SEQUESTRANT;
CREATINE KINASE;
EZETIMIBE;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
NICOTINIC ACID;
PITAVASTATIN;
PRAVASTATIN;
ROSUVASTATIN;
SIMVASTATIN;
UBIDECARENONE;
VITAMIN D;
BIOLOGICAL MARKER;
ACUTE CORONARY SYNDROME;
AGING;
ALGORITHM;
ARTICLE;
CLINICAL TRIAL (TOPIC);
DRUG HYPERSENSITIVITY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
ELECTRONIC MEDICAL RECORD;
EXERCISE;
HEART INFARCTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
LABORATORY TEST;
LIVER FUNCTION TEST;
MUSCLE RIGIDITY;
MUSCLE STRENGTH;
MYALGIA;
MYOPATHY;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
PHYSICAL ACTIVITY;
PRACTICE GUIDELINE;
PRESCRIPTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RESTLESSNESS;
STATIN INTOLERANCE;
ANIMAL;
BLOOD;
CHEMICALLY INDUCED;
CLINICAL PATHWAY;
DRUG EFFECTS;
DRUG SUBSTITUTION;
ENZYMOLOGY;
PAIN THRESHOLD;
PATHOPHYSIOLOGY;
PREDICTIVE VALUE;
PROGNOSIS;
RHABDOMYOLYSIS;
RISK FACTOR;
SKELETAL MUSCLE;
ALGORITHMS;
ANIMALS;
BIOMARKERS;
CREATINE KINASE;
CRITICAL PATHWAYS;
DRUG SUBSTITUTION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MUSCLE, SKELETAL;
MYALGIA;
PAIN THRESHOLD;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RHABDOMYOLYSIS;
RISK FACTORS;
|
EID: 84942833281
PISSN: 01609289
EISSN: 19328737
Source Type: Journal
DOI: 10.1002/clc.22432 Document Type: Article |
Times cited : (8)
|
References (4)
|